The Competition Commission has imposed a penalty of Rs 40 lakh on the investment manager of Goldman Sachs AIF for failing to ...

The Competition Commission of India (CCI) has fined Goldman Sachs AIF's investment manager Rs 40 lakh for not notifying a ...

Brokerages have turned bullish over Biocon's growth prospects after the US FDA clearance of the drugmaker's Malaysia unit ...

Aamar Deo Singh, senior vice president of research at Angel One, Sarvendra Srivastava, market strategist at 5wavesofficial ...

Ajit Mishra of Religare Broking suggests buying Biocon shares and Marico shares. He also suggests shorting Asian Paints ...

The Competition Commission penalises Goldman Sachs AIFs investment manager Rs 40 lakh for not notifying the Biocon deal, ...

Zomato slips on Jefferies' downgrade, Biocon rallies on USFDA approval and Jefferies upgrade, ONGC gains as CLSA names it a ...

HSBC expects an operational turnaround for Biocon, driven by major biosimilar launches and a rebound in generics sales. The ...

Raising overseas debt has become prohibitively expensive due to the depreciating rupee, he explained, adding, "several Indian ...

Clearance of Biocon's Malaysia unit puts an end to the drugmaker's regulatory hurdles and opens the door for the approval and ...

Biocon shares increased by 4.5% after the US FDA classified its Malaysian insulin facilities as Voluntary Action Indicated.

The Competition Commission of India has imposed a Rs 40 lakh penalty on Goldman Sachs AIMPL for not notifying the regulator ...